Home  |  Archive  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

Links

Meetings
Journals
Societies & Institutes
Hospitals
Databases & Libraries
Companies
Websites
Other links

 
Prostate Disease

Volume 21, Issue 2 (Mar 2019)
Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer
Logan P Rhea1, Brinda Gupta2, Jeanny B Aragon-Ching3
Asian J Androl 21: 107-108; 10.4103/aja.aja_88_18
Full TextPDF PDF

The current status of hormone treatment for prostate cancer patients in Korean real-world practice: a multi-institutional observational study
Jung Kwon Kim1, Jung Jun Kim1, Taek Won Gang2, Tae Kyun Kwon3, Hong Sup Kim4, Seung Chul Park5, Jae-Shin Park6, Jong-Yeon Park7, Seok Joong Yoon8, Youn-Soo Jeon9, Jin Seon Cho10, Kwan Joong Joo11, Sung-Hoo Hong12, Seok-Soo Byun1, the Korean Urological Oncology Society13
Asian J Androl 21: 115-120; 10.4103/aja.aja_95_18
Abstract |Full TextPDF PDF| Full Text@Pubmed Central

Clinical activity of abiraterone plus prednisone in docetaxel-naοve and docetaxel-resistant Chinese patients with metastatic castration-resistant prostate cancer
Guo-Wen Lin1,2, Gao-Xiang Li1,2, Bo Dai1,2, Ding-Wei Ye1,2, Yun-Yi Kong2,3, Yue Wang1,2, Yi-Jun Shen1,2
Asian J Androl 21: 131-136; 10.4103/aja.aja_85_18
Abstract |Full TextPDF PDF

Outcomes of men aged ≤50 years treated with radical prostatectomy: a retrospective analysis
Byeongdo Song1,2, Hakmin Lee1,2, Min Seung Lee1,2, Sung Kyu Hong1,2
Asian J Androl 21: 150-155; 10.4103/aja.aja_92_18
Abstract |Full TextPDF PDF

The therapeutic effect of pelvic floor muscle exercise on urinary incontinence after radical prostatectomy: a meta-analysis
Mei-Li-Yang Wu1,2, Cheng-Shuang Wang1, Qi Xiao1, Chao-Hua Peng1, Tie-Ying Zeng1
Asian J Androl 21: 170-176; 10.4103/aja.aja_89_18
Abstract |Full TextPDF PDF

The applied research of simultaneous image acquisition of T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) in the assessment of patients with prostate cancer
Yi Liu, Wei Wang, Xiu-Bo Qin, Hui-Hui Wang, Ge Gao, Xiao-Dong Zhang, Xiao-Ying Wang
Asian J Androl 21: 177-182; 10.4103/aja.aja_82_18
Abstract |Full TextPDF PDF

Separate Chinese lines for prostate cancer?
Finn Edler von Eyben
Asian J Androl 21: 212-212; 10.4103/aja.aja_71_18
Full TextPDF PDF

Volume 21, Issue 1 (Jan 2019)
The 14th international prostate forum
Mevlana Derya Balbay, Abdullah Erdem Canda
Asian J Androl 21: 1-2; 10.4103/aja.aja_108_18
Full TextPDF PDF

PSA screening - for whom and when?
Peter Albers
Asian J Androl 21: 3-5; 10.4103/aja.aja_37_17
Abstract |Full TextPDF PDF

Current and emerging trends in prostate cancer immunotherapy
Adam Schatz, Badar M Mian
Asian J Androl 21: 6-11; 10.4103/aja.aja_52_17
Abstract |Full TextPDF PDF

[首页] [前一页][后一页] [尾页]  共有50页,10条记录

 
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved